AGO/RISC-mediated antiviral RNA silencing in a plant in vitro system

Jana Schuck, Torsten Gursinsky, Vitantonio Pantaleo, J. Burgyán, Sven Erik Behrens

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

AGO/RISC-mediated antiviral RNA silencing, an important component of the plant's immune response against RNA virus infections, was recapitulated in vitro. Cytoplasmic extracts of tobacco protoplasts were applied that supported Tombusvirus RNA replication, as well as the formation of RNA-induced silencing complexes (RISC) that could be functionally reconstituted with various plant ARGONAUTE (AGO) proteins. For example, when RISC containing AGO1, 2, 3 or 5 were programmed with exogenous siRNAs that specifically targeted the viral RNA, endonucleolytic cleavages occurred and viral replication was inhibited. Antiviral RNA silencing was disabled by the viral silencing suppressor p19 when this was present early during RISC formation. Notably, with replicating viral RNA, only (+)RNA molecules were accessible to RISC, whereas (-)RNA replication intermediates were not. The vulnerability of viral RNAs to RISC activity also depended on the RNA structure of the target sequence. This was most evident when we characterized viral siRNAs (vsiRNAs) that were particularly effective in silencing with AGO1-or AGO2/RISC. These vsiRNAs targeted similar sites, suggesting that accessible parts of the viral (+)RNA may be collectively attacked by different AGO/RISC. The in vitro system was, hence, established as a valuable tool to define and characterize individual molecular determinants of antiviral RNA silencing.

Original languageEnglish
Pages (from-to)5090-5103
Number of pages14
JournalNucleic Acids Research
Volume41
Issue number9
DOIs
Publication statusPublished - May 2013

Fingerprint

RNA-Induced Silencing Complex
RNA Interference
Antiviral Agents
Viral RNA
RNA
RNA Virus Infections
Tombusvirus
Plant Immunity
RNA Cleavage
Plant Proteins
In Vitro Techniques
Protoplasts
Tobacco

ASJC Scopus subject areas

  • Genetics

Cite this

AGO/RISC-mediated antiviral RNA silencing in a plant in vitro system. / Schuck, Jana; Gursinsky, Torsten; Pantaleo, Vitantonio; Burgyán, J.; Behrens, Sven Erik.

In: Nucleic Acids Research, Vol. 41, No. 9, 05.2013, p. 5090-5103.

Research output: Contribution to journalArticle

Schuck, J, Gursinsky, T, Pantaleo, V, Burgyán, J & Behrens, SE 2013, 'AGO/RISC-mediated antiviral RNA silencing in a plant in vitro system', Nucleic Acids Research, vol. 41, no. 9, pp. 5090-5103. https://doi.org/10.1093/nar/gkt193
Schuck, Jana ; Gursinsky, Torsten ; Pantaleo, Vitantonio ; Burgyán, J. ; Behrens, Sven Erik. / AGO/RISC-mediated antiviral RNA silencing in a plant in vitro system. In: Nucleic Acids Research. 2013 ; Vol. 41, No. 9. pp. 5090-5103.
@article{3f4d732780794cd690a70230ee723d7a,
title = "AGO/RISC-mediated antiviral RNA silencing in a plant in vitro system",
abstract = "AGO/RISC-mediated antiviral RNA silencing, an important component of the plant's immune response against RNA virus infections, was recapitulated in vitro. Cytoplasmic extracts of tobacco protoplasts were applied that supported Tombusvirus RNA replication, as well as the formation of RNA-induced silencing complexes (RISC) that could be functionally reconstituted with various plant ARGONAUTE (AGO) proteins. For example, when RISC containing AGO1, 2, 3 or 5 were programmed with exogenous siRNAs that specifically targeted the viral RNA, endonucleolytic cleavages occurred and viral replication was inhibited. Antiviral RNA silencing was disabled by the viral silencing suppressor p19 when this was present early during RISC formation. Notably, with replicating viral RNA, only (+)RNA molecules were accessible to RISC, whereas (-)RNA replication intermediates were not. The vulnerability of viral RNAs to RISC activity also depended on the RNA structure of the target sequence. This was most evident when we characterized viral siRNAs (vsiRNAs) that were particularly effective in silencing with AGO1-or AGO2/RISC. These vsiRNAs targeted similar sites, suggesting that accessible parts of the viral (+)RNA may be collectively attacked by different AGO/RISC. The in vitro system was, hence, established as a valuable tool to define and characterize individual molecular determinants of antiviral RNA silencing.",
author = "Jana Schuck and Torsten Gursinsky and Vitantonio Pantaleo and J. Burgy{\'a}n and Behrens, {Sven Erik}",
year = "2013",
month = "5",
doi = "10.1093/nar/gkt193",
language = "English",
volume = "41",
pages = "5090--5103",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - AGO/RISC-mediated antiviral RNA silencing in a plant in vitro system

AU - Schuck, Jana

AU - Gursinsky, Torsten

AU - Pantaleo, Vitantonio

AU - Burgyán, J.

AU - Behrens, Sven Erik

PY - 2013/5

Y1 - 2013/5

N2 - AGO/RISC-mediated antiviral RNA silencing, an important component of the plant's immune response against RNA virus infections, was recapitulated in vitro. Cytoplasmic extracts of tobacco protoplasts were applied that supported Tombusvirus RNA replication, as well as the formation of RNA-induced silencing complexes (RISC) that could be functionally reconstituted with various plant ARGONAUTE (AGO) proteins. For example, when RISC containing AGO1, 2, 3 or 5 were programmed with exogenous siRNAs that specifically targeted the viral RNA, endonucleolytic cleavages occurred and viral replication was inhibited. Antiviral RNA silencing was disabled by the viral silencing suppressor p19 when this was present early during RISC formation. Notably, with replicating viral RNA, only (+)RNA molecules were accessible to RISC, whereas (-)RNA replication intermediates were not. The vulnerability of viral RNAs to RISC activity also depended on the RNA structure of the target sequence. This was most evident when we characterized viral siRNAs (vsiRNAs) that were particularly effective in silencing with AGO1-or AGO2/RISC. These vsiRNAs targeted similar sites, suggesting that accessible parts of the viral (+)RNA may be collectively attacked by different AGO/RISC. The in vitro system was, hence, established as a valuable tool to define and characterize individual molecular determinants of antiviral RNA silencing.

AB - AGO/RISC-mediated antiviral RNA silencing, an important component of the plant's immune response against RNA virus infections, was recapitulated in vitro. Cytoplasmic extracts of tobacco protoplasts were applied that supported Tombusvirus RNA replication, as well as the formation of RNA-induced silencing complexes (RISC) that could be functionally reconstituted with various plant ARGONAUTE (AGO) proteins. For example, when RISC containing AGO1, 2, 3 or 5 were programmed with exogenous siRNAs that specifically targeted the viral RNA, endonucleolytic cleavages occurred and viral replication was inhibited. Antiviral RNA silencing was disabled by the viral silencing suppressor p19 when this was present early during RISC formation. Notably, with replicating viral RNA, only (+)RNA molecules were accessible to RISC, whereas (-)RNA replication intermediates were not. The vulnerability of viral RNAs to RISC activity also depended on the RNA structure of the target sequence. This was most evident when we characterized viral siRNAs (vsiRNAs) that were particularly effective in silencing with AGO1-or AGO2/RISC. These vsiRNAs targeted similar sites, suggesting that accessible parts of the viral (+)RNA may be collectively attacked by different AGO/RISC. The in vitro system was, hence, established as a valuable tool to define and characterize individual molecular determinants of antiviral RNA silencing.

UR - http://www.scopus.com/inward/record.url?scp=84877273509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877273509&partnerID=8YFLogxK

U2 - 10.1093/nar/gkt193

DO - 10.1093/nar/gkt193

M3 - Article

C2 - 23535144

AN - SCOPUS:84877273509

VL - 41

SP - 5090

EP - 5103

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 9

ER -